Drug Database
Back to search

Ireland· IE-PA-PA0822/127/001

Edronax® 4 mg tablets

A reboxetine product containing reboxetine, registered in Ireland by Pfizer Healthcare Ireland Unlimited Company. The same ATC class is registered in 8 of our 19 countries.

ATC N06AX18

Checked against HPRA (Ireland) on

Informational only — not a medical device.

SOURCE REGISTER · IEHPRA (Ireland)normalisedEdronax® 4 mg tabletsATCN06AX18REGISTER NO.IE-PA-PA0822/127/001PACKS LISTED1CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about reboxetineAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Reboxetine is registered in 8 of 19 countries.

Countries holding a registration under ATC N06AX18 (reboxetine), each read from that country’s own register.

  • This record: Ireland, from HPRA (Ireland)
  • 5 of them publish a price we can compare per daily dose
Search reboxetine products by name

Reboxetine · ATC N06AX18

8 / 19 countries

  • Belgiumprice
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of reboxetine costs, country by country.

Normalised to the WHO defined daily dose (8 mg), the median price runs from $1.04 in Italy to $2.27 in Switzerland — a ×2.2 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Reboxetine · price per daily dose (8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$2.27
  • IT Italy$1.04
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

HPRA (Ireland)
Active substance
Reboxetine
Manufacturer
Pfizer Healthcare Ireland Unlimited Company
Country
Ireland (IE)
ATC code
N06AX18
ATC class
Reboxetine
Defined daily dose
8 mg, O
Reimbursed
Not published by this register
Source register
HPRA (Ireland)
Last checked
September 28, 2026

Packs & prices · 1

  • ie_pa_number
    PA0822/127/001

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

19 interactions on record for reboxetine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check reboxetine against other medicinesHow interaction checks work

Reboxetine · interactions on record

19 records

19 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Reboxetine in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All reboxetine products

Authorised across Europe · EMA

The same active substance is authorised in 13 EEA countries. Names it is sold under:

  • Austria · Edronax
  • Belgium · Edronax
  • Bulgaria · Едронакс
  • Germany · Edronax
  • Spain · Irenor, Norebox
  • United Kingdom (Northern Ireland) · Edronax
  • Croatia · Edronax
  • Italy · Edronax
  • Luxembourg · Edronax
  • Poland · Edronax
  • Portugal · Edronax
  • Sweden · Edronax
  • Slovenia · Edronax

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/5c015715-b5f0-46b6-b1b4-1e230744bef1
GET /v1/drugs/5c015715-b5f0-46b6-b1b4-1e230744bef1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "routes": [
    "Oral use"
  ],
  "source": "hpra",
  "atc_all": [
    "N06AX",
    "N06AX18"
  ],
  "strength": null,
  "pa_number": "PA0822/127/001",
  "substances": [
    "Reboxetine"
  ],
  "legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
  "market_info": "Marketed",
  "authorised_at": "28/11/1997",
  "dispensing_status": "Product subject to prescription which may not be renewed (A)",
  "registration_status": "AU",
  "supply_legal_status": "Supply through pharmacies only",
  "interchangeable_code": null
}
API referenceMCP serverPlans

See everything about reboxetine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console